You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美單日新增10.63萬宗新冠確診 FDA小組商討莫德納及強生使用加強劑
阿思達克 10-13 15:05
美國新冠疫情緩和。據美國約翰霍普斯大學統計,截至美國西岸時間昨日(10日)午夜,美國累計新冠確診44,562,287宗,單日新增106,328宗。累計新冠死亡716,477宗,單日新增2,420宗。 美國食品及藥物管理局(FDA)獨立顧問小組將於明日(14日)開會,討論是否批準爲己接種莫德納(Moderna)或強生新冠疫苗人士接種加強劑,預期最終批準最少要等待一週。另外,加州累計新冠死亡個案於週一(11日)達到7萬宗,當地去年新冠疫情爆發時,單日死亡人數曾升至700,於最新一輪新冠疫情中,單日死亡人數仍逾百人。 美國過去八日每日新冠疫情統計: 日期│累計確診│單日新增確診│累計死亡│單日新增死亡 10月12日(二)│44,562,287宗│+106,828宗│716,477宗│+2,420宗 10月11日(一)│44,455,959宗│+116,129宗│714,057宗│+ 707宗 10月10日(日)│44,339,830宗│+ 22,277宗│713,350宗│+ 376宗 10月 9日(六)│44,317,553宗│+ 27,460宗│712,974宗│+ 279宗 10月 8日(五)│44,290,093宗│+131,104宗│712,695宗│+2,517宗 10月 7日(四)│44,158,989宗│+100,108宗│710,178宗│+2,390宗 10月 6日(三)│44,058,881宗│+110,870宗│707,788宗│+2,594宗 10月 5日(二)│43,948,011宗│+ 95,746宗│705,194宗│+1,909宗
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account